Advertisement
Previously, Sembler was vice president, Oncology, for the U.S.pharmaceuticals organization and was responsible for all aspects of Roche'sU.S.-based oncology business.
Advertisement
"In his role as vice president of Oncology, Steve demonstrated how a keenstrategic mind, coupled with a laser-like focus on the marketplace, can driveperformance for our oncology products," said George B. Abercrombie, presidentand CEO, Hoffmann-La Roche Inc. "I am very pleased to have him join mymanagement team and confident that the accomplishments we have seen within theoncology franchise will be evident in his new role as well."
"I am very excited to take on this new role within the U.S.pharmaceuticals organization. I look forward to working with all of the peoplewithin my expanded areas of responsibility as we continue to grow the U.S.business to new heights across these key franchises," said Sembler.
Sembler has more than 25 years of experience in the pharmaceuticalindustry and has been involved in oncology since 1985. Before joining Roche in2004, he had a distinguished career with GlaxoSmithKline (GSK), BMS and thePurdue Frederick Company, where he assumed positions of increasingresponsibility in the field, sales management, marketing, new productdevelopment and lifecycle management. His efforts in these areas led to thedevelopment and commercialization of numerous key oncology therapeutics, whichare utilized today in treating cancer patients.
Throughout his career, Sembler has also been a strong supporter, advisorand key advocate of numerous oncology patient advocacy organizations anddeveloped a passion for ensuring patient access to innovative therapies.
A native of Kansas City, Missouri, Sembler holds a Bachelor of Arts fromthe University of Missouri. He is married and has two children.
About Roche
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S.pharmaceuticals headquarters of the Roche Group, one of the world's leadingresearch-oriented healthcare groups with core businesses in pharmaceuticalsand diagnostics. For more than 100 years in the U.S., Roche has been committedto developing innovative products and services that address prevention,diagnosis and treatment of diseases, thus enhancing people's health andquality of life. An employer of choice, in 2007 Roche was named Top Company ofthe Year by Med Ad News, one of the Top 20 Employers (Science) and ranked theNo. 1 Company to Sell For (Selling Power). In previous years, Roche has beennamed as a Top Company for Older Workers (AARP) and one of the Best Companiesto Work For in America (Fortune). For additional information about the U.S.pharmaceuticals business, visit our websites: http://www.rocheusa.com orwww.roche.us.
All trademarks used or mentioned in this release are protected by law.
SOURCE Roche
